Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Current Medical Research and Opinion
|
July 7, 2018
Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
Lindsay Claxton, Matthew Taylor, Robert A Gerber, et al.
Rheumatology (Oxford, England)
|
August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years
Janet Pope, Louis Bessette, Niall Jones, et al.
Clinical Therapeutics
|
June 6, 2022
Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination
Stanley B Cohen, Boulos Haraoui, Jeffrey R Curtis, et al.
Arthritis Research & Therapy
|
November 5, 2015
Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs
Vibeke Strand, Joel Kremer, Gene Wallenstein, et al.
Digestive Diseases (Basel, Switzerland)
|
December 8, 2021
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis
Millie D Long, Russell D Cohen, Timothy W Smith, et al.
Rheumatology and Therapy
|
April 13, 2026
Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL Study
Boulos Haraoui, Denis Choquette, Cristina Sciortino, et al.
Rheumatology and Therapy
|
November 11, 2019
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
George W Reed, Robert A Gerber, Ying Shan, et al.
Arthritis Research & Therapy
|
September 25, 2016
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Robert B M Landewé, Carol A Connell, John D Bradley, et al.
BMJ Open
|
December 25, 2025
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials
Vibeke Strand, Hendrik Schulze-Koops, Samar Al-Emadi, et al.
Arthritis Care & Research
|
September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial
Vibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Current Medical Research and Opinion
|
July 7, 2018
Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
Lindsay Claxton, Matthew Taylor, Robert A Gerber, et al.
Rheumatology (Oxford, England)
|
August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years
Janet Pope, Louis Bessette, Niall Jones, et al.
Clinical Therapeutics
|
June 6, 2022
Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination
Stanley B Cohen, Boulos Haraoui, Jeffrey R Curtis, et al.
Arthritis Research & Therapy
|
November 5, 2015
Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs
Vibeke Strand, Joel Kremer, Gene Wallenstein, et al.
Digestive Diseases (Basel, Switzerland)
|
December 8, 2021
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis
Millie D Long, Russell D Cohen, Timothy W Smith, et al.
Rheumatology and Therapy
|
April 13, 2026
Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL Study
Boulos Haraoui, Denis Choquette, Cristina Sciortino, et al.
Rheumatology and Therapy
|
November 11, 2019
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
George W Reed, Robert A Gerber, Ying Shan, et al.
Arthritis Research & Therapy
|
September 25, 2016
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Robert B M Landewé, Carol A Connell, John D Bradley, et al.
BMJ Open
|
December 25, 2025
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials
Vibeke Strand, Hendrik Schulze-Koops, Samar Al-Emadi, et al.
Arthritis Care & Research
|
September 5, 2014
Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial
Vibeke Strand, Gerd R Burmester, Cristiano A F Zerbini, et al.
Page
of 7